share_log
Moomoo 24/7 ·  Apr 3 14:43
FibroGen Shares Are Trading Lower After the Company Announced Topline Results From the Phase 1 Monotherapy Study of FG-3246 in Patients With Metastatic Castration-resistant Prostate Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment